Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
J Formos Med Assoc
; 121(5): 1003-1007, 2022 May.
Article
in English
| MEDLINE | ID: covidwho-1599090
ABSTRACT
Pityriasis rosea (PR) is a self-limited disease with exanthematous papulosquamous rashes mostly associated with reactivation of human herpesvirus (HHV)-6 or HHV-7. PR-like eruptions, which occur along with peripheral eosinophilia, interface dermatitis, and eosinophils on histopathology, may result from medications or vaccinations. Previously, PR-like eruptions had been noted following vaccination for influenza or other vaccines. During this pandemic, acute COVID-19 infection has been related to PR or PR-like eruptions in several cases. Various COVID-19 vaccines associated with PR-like eruptions were rarely reported. Herein, we report a case of cutaneous PR-like eruptions following COVID-19 mRNA-1273 vaccination.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pityriasis Rosea
/
Herpesvirus 6, Human
/
Exanthema
/
COVID-19
Type of study:
Case report
/
Observational study
/
Reviews
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Formos Med Assoc
Journal subject:
Medicine
Year:
2022
Document Type:
Article
Affiliation country:
J.jfma.2021.12.028
Similar
MEDLINE
...
LILACS
LIS